Skip to content

Clinical study on the efficacy of postural control combined with electroacupuncture in treating dysphagia after stroke.

Clinical study on the efficacy of postural control combined with electroacupuncture in treating dysphagia after stroke.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075870
Enrollment
Unknown
Registered
2023-09-18
Start date
2021-08-10
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia caused by stroke

Interventions

Control group:Conventional rehabilitation training+electroacupuncture
Treatment group:Conventional rehabilitation training + postural control + electroacupuncture

Sponsors

Gezhouba Central Hospital of Sinopharm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1)Patients who meet the diagnostic criteria for stroke, as defined by both Traditional Chinese Medicine (TCM) (in line with the "Scoring Standards for Stroke Diagnosis" issued by the Encephalopathy Collaborative Group of the State Administration of Traditional Chinese Medicine) and Western medicine (diagnostic criteria for cerebral infarction or cerebral hemorrhage in the "Key Points for the Diagnosis of Various Major Cerebrovascular Diseases in China 2019"). Additionally, the duration of their disease should be between 15 days to 6 months; 2) Patients who undergo repeated saliva swallowing tests and have their throat lowered before fully lifting or can successfully complete the first swallowing action but cannot complete the next swallowing action; 3) Swallowing dysfunction was confirmed through swallowing contrast examination; 4) Absence of any other neurological diseases; 5) Patients having stable vital signs and willingness to cooperate with therapists for rehabilitation training and examination.

Exclusion criteria

Exclusion criteria: 1)Patients with concurrent diseases such as oropharyngeal lesions (pharyngitis, pharyngeal tumors, posterior pharyngeal wall abscesses, etc.), esophageal lesions (esophagitis, esophageal cancer, cardiac spasm, etc.), or psychiatric diseases (hysteria, etc.); 2) Patients with ulcers and a tendency to bleed easily; 3) Patients with organ failure that could significantly impact their health; 4) Individuals experiencing combined consciousness and mental disorders.

Design outcomes

Primary

MeasureTime frame
Standardized swallowing assessment;Water swallow test;Videofluoroscopic swallowing study;

Countries

China

Contacts

Public ContactYanli Wu

Gezhouba Central Hospital of Sinopharm

1758394788@qq.com+86 188 7717 5140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026